Pharmacogenomics

Precision medicine

Genomic Associations with Brain Metastasis and Progression in Colorectal Cancer Identified

A recent study published in Neuro-Oncology has identified novel genomic associations with brain metastasis and progression in colorectal cancer, offering a potential basis for personalized clinical management. Researchers at Memorial Sloan-Kettering Cancer Center analyzed next-generation sequencing data from patients with colorectal cancer to identify genomic features associated with brain metastasis

Precision medicine

Personalized Medicine Breakthroughs in Cholangiocarcinoma Research

Researchers from Lanzhou University have made significant discoveries in the field of personalized medicine, shedding new light on the role of glycerol-3-phosphate dehydrogenase 2 (GPD2) in cholangiocarcinoma (CCA). The study employed a comprehensive multi-omics approach to explore GPD2's function across various cancers, with a focus on CCA. The

Precision medicine

Breakthrough in Personalized Medicine: Novel Assay for Enhanced Molecular Profiling and CNS Monitoring

Researchers from the Molecular Genetics Laboratory have developed a novel assay that simultaneously detects mutations, immunoglobulin (IG) fusions, and IG V(D)J clonality in plasma and cerebrospinal fluid (CSF) to enhance molecular profiling and CNS monitoring in diffuse large B-cell lymphoma (DLBCL) patients. This non-invasive approach offers improved sensitivity

Pharmacogenomics

Breakthrough in Personalized Medicine: Novel Assay for Enhanced Molecular Profiling and CNS Monitoring

Researchers from the Molecular Genetics Laboratory have developed a novel assay that simultaneously detects mutations, immunoglobulin (IG) fusions, and IG V(D)J clonality in plasma and cerebrospinal fluid (CSF) to enhance molecular profiling and CNS monitoring in diffuse large B-cell lymphoma (DLBCL) patients. This non-invasive approach offers improved sensitivity